跳至主要内容
临床试验/NL-OMON44685
NL-OMON44685招募中2 期

Metformin and sitagliptin in patients with impaired glucose tolerance and a recent TIA or minor ischemic stroke - safety and feasibility - MAAS trial

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - 18 years or older
  • - clinical diagnosis of TIA, amaurosis fugax or minor ischemic stroke within the previous 6 months
  • - impaired glucose tolerance (2-hour post-load glucose level 7.8-11.0mmol/L)

排除标准

  • - diabetes mellitus
  • - history of diabetic ketoacidosis
  • - symptoms of type 1 diabetes mellitus
  • - signs of renal impairment (creatinin of 135 µmol/L or higher for men, and 110 µmol/L or higher for women)
  • - known liver disease or disturbed liver function tests (alanine amino transferase, aspartate amino transferase, alkaline phosphatase, or γ glutamyl transferase increased to more than twice the upper limit of typical values)
  • - history of lactic acidosis
  • - heart failure requiring pharmacological therapy
  • - pancreatitis
  • - chronic hypoxic lung disease
  • - use of digoxin
  • - pregnancy
  • - breast feeding

研究者

相似试验